These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18771157)

  • 21. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
    Vanderbrink BA; Gitlin J; Toro S; Palmer LS
    J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of biofeedback treatment on reflux resolution rates in children with dysfunctional voiding and vesicoureteral reflux.
    Kibar Y; Ors O; Demir E; Kalman S; Sakallioglu O; Dayanc M
    Urology; 2007 Sep; 70(3):563-6; discussion 566-7. PubMed ID: 17905115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunctional voiding: the importance of non-invasive urodynamics in diagnosis and treatment.
    Clothier JC; Wright AJ
    Pediatr Nephrol; 2018 Mar; 33(3):381-394. PubMed ID: 28567611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vesicoureteral reflux and elimination disorders.
    Alova I; Lottmann HB
    Arch Esp Urol; 2008 Mar; 61(2):218-28. PubMed ID: 18491738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of biofeedback treatment on voiding and urodynamic parameters in children with voiding dysfunction.
    Yagci S; Kibar Y; Akay O; Kilic S; Erdemir F; Gok F; Dayanc M
    J Urol; 2005 Nov; 174(5):1994-7; discussion 1997-8. PubMed ID: 16217376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home uroflowmetry biofeedback in behavioral training for dysfunctional voiding in school-age children: a randomized controlled study.
    Klijn AJ; Uiterwaal CS; Vijverberg MA; Winkler PL; Dik P; de Jong TP
    J Urol; 2006 Jun; 175(6):2263-8; discussion 2268. PubMed ID: 16697850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urodynamics.
    Robertson TM; Hamlin AS
    Crit Care Nurs Clin North Am; 2010 Mar; 22(1):109-20. PubMed ID: 20193885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable neuromodulatory agents: botulinum toxin therapy.
    Frenkl TL; Rackley RR
    Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and management of voiding disorders in children.
    Koff SA
    Urol Clin North Am; 1988 Nov; 15(4):769-75. PubMed ID: 3055626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current perspectives on management of urgency using bladder and behavioral training.
    Burgio KL
    J Am Acad Nurse Pract; 2004 Oct; 16(10 Suppl):4-7. PubMed ID: 15543926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating children with nonneurogenic voiding disorders--can we do better?
    Glassberg KI
    J Urol; 2008 Oct; 180(4):1226-7. PubMed ID: 18707742
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study.
    McClurg D; Ashe RG; Marshall K; Lowe-Strong AS
    Neurourol Urodyn; 2006; 25(4):337-48. PubMed ID: 16637070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F; Cocuzza M; Gomes CM; Leão N
    Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drooling of saliva: a review of the etiology and management options.
    Meningaud JP; Pitak-Arnnop P; Chikhani L; Bertrand JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jan; 101(1):48-57. PubMed ID: 16360607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of pelvic-floor therapy in the treatment of lower urinary tract dysfunctions in children.
    De Paepe H; Renson C; Hoebeke P; Raes A; Van Laecke E; Vande Walle J
    Scand J Urol Nephrol; 2002; 36(4):260-7. PubMed ID: 12201917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children.
    Nijman RJ
    Urology; 2004 Mar; 63(3 Suppl 1):45-50. PubMed ID: 15013652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower urinary tract dysfunction in childhood.
    Ballek NK; McKenna PH
    Urol Clin North Am; 2010 May; 37(2):215-28. PubMed ID: 20569800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-neurogenic lower urinary tract dysfunction].
    Skobejko-Włodarska L
    Pol Merkur Lekarski; 2008; 24 Suppl 4():131-7. PubMed ID: 18924526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advantages and limitations of single-channel urodynamics in childhood].
    Szabó L; Borbás E
    Orv Hetil; 1992 Dec; 133(51):3253-6. PubMed ID: 1475110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.